Literature DB >> 29593467

Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.

Antonio B Porcaro1, Daniele Mattevi1, Giovanni Novella1, Nicolò De Luyk1, Paolo Corsi1, Leonardo Bizzotto1, Davide De Marchi1, Marco Sebben1, Alessandro Tafuri1, Davide Inverardi1, Tania Processali1, Maria A Cerruto1, Matteo Brunelli2, Salvatore Siracusano1, Walter Artibani1.   

Abstract

OBJECTIVES: To investigate associations of the transitional zone volume (TZV) with intraprostatic chronic inflammatory infiltrate (CII) and prostate cancer (PCa) risk in patients undergoing a first random biopsy set.
MATERIALS AND METHODS: The study included a homogenous population of 596 patients. The volume of the prostate and TZV were separately measured. Independent associations were investigated by multivariate logistic regression analysis.
RESULTS: The median TZV was 18 ml, CII was detected in 157 cases (26.3%), and PCa was present in 292 patients (49%). TZV was the only independent clinical factor associated with CII risk (OR = 1.014). After correcting for CII (OR = 0.276; p < 0.0001), independent factors associated with PCa risk included age (OR = 1.066), prostate specific antigen (OR = 1.177), TZV (OR = 0.919), and an abnormal digital rectal exam (OR = 2.024).
CONCLUSION: In a patient population undergoing a first random prostate biopsy set because of suspected cancer, independent associations were detected among TZV, CII, and PCa. The association between TZV and CII was direct, but the relation between TZV and PCa was inverse. The measurement of the volume of the transitional zone was a useful parameter for evaluating chronic intraprostatic inflammation and PCa risk.

Entities:  

Keywords:  Chronic prostate inflammation; Prostate biopsy; Prostate cancer; Prostate volume; Prostate-specific antigen; Transitional zone volume

Year:  2017        PMID: 29593467      PMCID: PMC5836179          DOI: 10.1159/000447199

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  22 in total

1.  NIH consensus definition and classification of prostatitis.

Authors:  J N Krieger; L Nyberg; J C Nickel
Journal:  JAMA       Date:  1999-07-21       Impact factor: 56.272

2.  Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation.

Authors:  L Hoekx; W Jeuris; E Van Marck; J J Wyndaele
Journal:  Acta Urol Belg       Date:  1998-10

3.  High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy. Pathologist Multi Center Study Group.

Authors:  J Irani; J M Goujon; E Ragni; L Peyrat; J Hubert; F Saint; N Mottet
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

Review 4.  Prostate carcinogenesis and inflammation: emerging insights.

Authors:  Ganesh S Palapattu; Siobhan Sutcliffe; Patrick J Bastian; Elizabeth A Platz; Angelo M De Marzo; William B Isaacs; William G Nelson
Journal:  Carcinogenesis       Date:  2004-10-21       Impact factor: 4.944

5.  Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen.

Authors:  W Zhang; I A Sesterhenn; R R Connelly; F K Mostofi; J W Moul
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

6.  Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.

Authors:  P I Karakiewicz; S Benayoun; L R Bégin; A Duclos; L Valiquette; M McCormack; F Bénard; F Saad; P Perrotte
Journal:  Int J Clin Pract       Date:  2007-03       Impact factor: 2.503

Review 7.  The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis.

Authors:  W W Hochreiter
Journal:  Andrologia       Date:  2008-04       Impact factor: 2.775

8.  Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

Authors:  Phillip M Pierorazio; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

9.  Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.

Authors:  Antonio Benito Porcaro; Giovanni Novella; Giovanni Cacciamani; Davide De Marchi; Paolo Corsi; Nicolò De Luyk; Leonardo Bizzotto; Tania Processali; Mattia Cerasuolo; Irene Tamanini; Maria Angela Cerruto; Matteo Brunelli; Salvatore Siracusano; Walter Artibani
Journal:  Urol Int       Date:  2016-07-05       Impact factor: 2.089

Review 10.  Prostatitis and serum prostate-specific antigen.

Authors:  Puneet Sindhwani; Christopher M Wilson
Journal:  Curr Urol Rep       Date:  2005-07       Impact factor: 2.862

View more
  3 in total

1.  Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy.

Authors:  Antonio B Porcaro; Alessandro Tafuri; Marco Sebben; Giovanni Novella; Tania Processali; Marco Pirozzi; Nelia Amigoni; Riccardo Rizzetto; Aliasger Shakir; Arianna Mariotto; Matteo Brunelli; Maria Angela Cerruto; Giovanni Enrico Cacciamani; Filippo Migliorini; Salvatore Siracusano; Walter Artibani
Journal:  World J Urol       Date:  2019-06-01       Impact factor: 4.226

2.  Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors.

Authors:  Alessandro Tafuri; Marco Sebben; Giovanni Novella; Marco Pirozzi; Tania Processali; Aliasger Shakir; Riccardo Rizzetto; Nelia Amigoni; Riccardo Bernasconi; Matteo Brunelli; Maria A Cerruto; Salvatore Siracusano; Alessandro Antonelli; Walter Artibani; Antonio B Porcaro
Journal:  Arab J Urol       Date:  2020-05-13

3.  Prostate volume index and prostatic chronic inflammation have an effect on tumor load at baseline random biopsies in patients with normal DRE and PSA values less than 10 ng/ml: results of 564 consecutive cases.

Authors:  Antonio B Porcaro; Alessandro Tafuri; Marco Sebben; Aliasger Shakir; Giovanni Novella; Marco Pirozzi; Tania Processali; Riccardo Rizzetto; Nelia Amigoni; Leone Tiso; Clara Cerrato; Matteo Brunelli; Maria Angela Cerruto; Filippo Migliorini; Salvatore Siracusano; Walter Artibani
Journal:  Ther Adv Urol       Date:  2019-08-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.